Company Is Also Recognized as a Leader in the IDC MarketScape: Worldwide Unified Endpoint Management Software 2025–2026 Vendor Assessment ManageEngine scores above 4 out of 5 across all four Gartner ® ...
New AAV therapy for retinitis pigmentosa completes Phase I/II dosing, aiming to protect cones and slow vision loss; first readout targets 2027. SPVN06, a novel gene-agnostic adeno-associated virus ...
The MarketWatch News Department was not involved in the creation of this content. Company Is Also Recognized as a Leader in the IDC MarketScape: Worldwide Unified Endpoint Management Software ...
Company Is Also Recognized as a Leader in the IDC MarketScape: Worldwide Unified Endpoint Management Software 2025–2026 Vendor Assessment ManageEngine scores above 4 out of 5 across all four Gartner® ...
ManageEngine Is Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Endpoint Management Tools, scoring above 4/5 across all 4 Use Cases Company Is Also Recognized as a Leader in the IDC ...
Company Is Also Recognized as a Leader in the IDC MarketScape: Worldwide Unified Endpoint Management Software 2025–2026 Vendor Assessment AUSTIN, Texas — ManageEngine, a division of Zoho Corporation ...
AUSTIN, Texas--(BUSINESS WIRE)--ManageEngine, a division of Zoho Corporation and a leading provider of enterprise IT management solutions, today announced that it was named a Challenger in the 2026 ...
Boutique MedTech CRO gains access to unified eClinical platform with wholesale pricing, training, and joint marketing ...
In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results